Quarterly report pursuant to Section 13 or 15(d)

Restatement of Condensed Consolidated Financial Statements (Details)

v3.22.1
Restatement of Condensed Consolidated Financial Statements (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Net revenue [1] $ 216,818 $ 88,592 $ 563,461 $ 218,497
License fees and revenue share [1] 109,053 50,144 284,369 122,976
Other direct costs of revenue [1] 9,090 749 21,385 1,971
Product development [1] 13,755 5,202 40,594 13,827
Sales and marketing [1] 15,857 5,219 47,072 14,372
General and administrative [1] 39,924 6,761 105,225 22,096
Total costs of revenue and operating expenses [1] 187,679 68,075 498,645 175,242
Income from operations [1] 29,139 $ 20,517 64,816 $ 43,255
Reported        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Net revenue 375,487   898,307  
License fees and revenue share 267,722   619,215  
Other direct costs of revenue 5,125   11,496  
Product development 17,720   51,171  
Sales and marketing 15,857   47,072  
General and administrative 39,924   104,537  
Total costs of revenue and operating expenses 346,348   833,491  
Income from operations 29,139   64,816  
Adjustment        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Net revenue (158,669)   (334,846)  
License fees and revenue share (158,669)   (334,846)  
Other direct costs of revenue 3,965   9,889  
Product development (3,965)   (10,577)  
Sales and marketing 0   0  
General and administrative 0   688  
Total costs of revenue and operating expenses (158,669)   (334,846)  
Income from operations $ 0   $ 0  
[1] In the fiscal quarter ended June 30, 2021, the Company initiated two significant acquisitions. Please refer to Note 4 in the accompanying condensed consolidated financial statements.